The EBF steering committee is interested to learn from the delegates, sponsors and speakers, who visited the 4th Open symposium, how they experienced and valued the meeting. With the aid of your opinion we can maintain the high quality of our meetings and bring you again a better program next year. Filling in the survey is anonymous and will only take a few minutes of your time.
Day 1 – 16 November 2011
| |||
MORNING PLENARY SESSIONS
| |||
12.45
|
How To Implement The EMA Guideline On Bioanalytical Method Validation
| ||
Chair and Moderator: Silke Luedtke (Boehringer-Ingelheim)
| |||
11.20
|
11.25
|
Peter van Amsterdam (on behalf of EBF)
| |
Introduction
| |||
11.25
|
11.35
|
Olivier Le Blaye (afssaps)
| |
< Title to be confirmed >
| |||
11.35
|
11.45
|
Timothy Sangster (Charles River Laboratories)
| |
EMA – have our prayers been answered!
| |||
11.45
|
11.55
|
Daniela Stoellner (Novartis)
| |
New EMA guideline on method validation and how it translates into best practice for Ligand Binding Assays
| |||
11.55
|
12.05
|
Graeme Smith (Huntingdon Life Sciences)
| |
Partial Validation when is enough, enough?
| |||
12.05
|
12.15
|
Morten Rohde (Lundbeck)
| |
Matrix Effects in Bioanalysis, when established procedures become obsolete.
| |||
12.15
|
12.45
|
Panel Discussion
| |
Posts
All Comments
